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Purpose: The purpose of this study was to evaluate the expression of prostaglandin E 2 
(PGE2) and the two cyclooxygenase i oforms (cox1 and cox2) in human abdominal aortic 
aneurysm (AAA) tissue. 
Methods: Ten specimens each of normal aortas and aneurysmal ortas were collected and 
used for histologic analysis and whole organ culture. An enzyme-linked immunosOrbent 
assay for PGU, 2 was  performed on the media from the aortic explant whole organ culture. 
An immunohistochemical analysis for I~GE2 was  performed, as was in situ hybridization 
for cox1 and cox2 on tissue sections. 
Results: PGE 2 production of AAA specimens was found to be 67,287 -+ 27,303 pg/ml  as 
compared with 1698 -+ 858 pg/ml  for normal aortic specimens (p < 0.001). PGE 2 was 
localized by immunohistochemical analysis to the inflammatory infiltrate in AAAs. 
Minimal expression was noted in normal aortas. Using in situ hybridization, little 
expression of cox1 was noted in either the normal or the AAA specimens. Cox2 was 
expressed by macrophage-like c lls within the inflammatory infiltrate of the AAA speci- 
mens but was not significantly expressed in the normal aorta. 
Conclusion: The expression of PGE 2 is associated with the pathogenesis of human AAAs. 
Its expression is localized to macrophage-like c lls within the inflammatory infiltrate and 
is controlled by the cox2 isoform of cyclooxygenase. Cox2 is, therefore, a potential target 
for pharmacotherapy ofAAAs. (J Vasc Surg 1997;25:810-5.) 
The pathogenesis of abdominal aortic aneurysms 
(AAAs) remains poorly understood. The inflamma- 
tory response that is associated with AAAs appears to 
play an important role in the destruction of the 
elastin of the aortic wall that is characteristic of the 
disease. 1-4 This inflammatory infiltrate includes B 
and T lymphocytes, plasma cells, and macrophages. 
Macrophages in particular have been implicated in 
this destructive process, and their effects appear to be 
mediated, at least in part, through the expression of 
matrix metalloproteinases (MMPs). s,6 MMP expres- 
sion in macrophages is dependent on prostaglandin 
E 2 (PGE2). 7-1° PGE 2 is synthesized from arachidonic 
acid, and cyclooxygenase is the rate-limiting enzyme 
in this pathway. There are two isoenzymes of cyclo- 
oxygenase, which are encoded by two independently 
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regulated genes, cyclooxygenase 1 (coxl) and cyclo- 
oxygenase 2 (cox2). ha2 
The purpose of this study was to evaluate the 
production o fPGE 2 and the differential expression of 
coxl and cox2 in AAA tissue and compare this with 
normal aortic tissue, hypothesizing that PGE 2 and 
cyclooxygenase are intermediaries involved in the 
pathogenesis ofAAA. 
METHODS 
Human aortic tissues. Full-thiclmcss pecimens 
of normal infrarenal abdominal aorta that did not 
have any visible evidence of atherosclerosis were ob- 
tained in the operating room from healthy organ 
transplantation donors at the time of organ harvest. 
Tissue specimens were also obtained from patients 
who underwent aortic reconstruction procedures for 
AAAs from the anterior wall of  the mid-infrarenal 
aorta. All studies were performed with approval by 
the Washington University School of Medicine Hu- 
man Research Subjects Committee. For each speci- 
men obtained, one portion of  the aortic wall was 
used for the aortic cultures and an adjacent portion 
was processed for the histologic studies. 
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Fig. 1. Raw data for ELISA for PGE 2. There were ten specimens in each category. Of note is 
that PGE z levels in culture media of AAA specimens are in all instances an order of magnitude 
greater than in normal group. 
Immunohistochemical  nalysis. Fresh aortic 
tissue samples were rinsed free of blood with normal 
saline solution, fixed in 10% neutral formalin at 4 ° C 
for 24 hours, processed for routine paraffin embed- 
ding, and then sectioned (5 Ixm). The sections were 
deparaffinized and rehydrated, and endogenous per- 
oxidase activity was quenched by incubation with 
0.3% H202 at room temperature for 30 minutes. 
Samples were then incubated with affinity-purified 
mouse-antihuman PGE 2 (1:500, Monsanto, St. 
Louis) or 10% horse serum, and immune complexes 
were detected with immunoperoxidase staining us- 
ing a Vectastain Elite ldt (Vector Laboratories, Inc., 
Burlinghame, Calif.). The sections were then coun- 
terstained in preparation for the histologic analysis. 
Aortic organ cultures. Ten specimens each of 
normal aorta and aneurysmal orta were transported 
to a sterile tissue culture hood in cold (4 ° C) Dulbec- 
co's modified Eagle's media supplemerited with 1% 
bovine serum albumin and antibiotics. Each speci- 
men was divided into 2 mm 2 segments of  full-thick- 
ness aortic wall, and these segments were placed into 
separate wells of six-tissue culture plates. After 20 
minutes to allow adherence to the tissue culture 
plate, each well was supplemented with 1.5 ml of 
culture medium, and the plates were incubated at 
37 ° C in a humidified 5% CO 2 atmosphere. After 72 
hours, the conditioned media was collected and 
stored at -20 ° C until they were used for enzyme- 
linked immunosorbent assay (ELISA). 
ELISA. The PGE 2 content in the culture media 
from aortic explant whole organ culture samples was 
quantified by competitive-binding i direct ELISA as 
described. 13 The assay was performed on a total of 20 
specimens (10 normal, 10 AAA). Standards curves 
were included in each assay using purified human 
PGE 2. Statistical analysis was performed using a 
paired t test, with statistical significance being de- 
fined as a p value less than 0.05. 
In situ hybridization. Probes for in situ hybrid- 
ization were prepared as described by Stahl-Backdahl 
et al.l~ Briefly, a 400 base-pair (bp) fragment of the 
3' end of human cox2 cDNA (pMON #23907, 
Monsanto) and a 240 bp fragment of the 3' end of 
human coxl eDNA (pMON #23914, Monsanto) 
were each subcloned in pGEM5Z transcription vec- 
tors (Promega, Madison, Wis.) and then linearized. 
The RNA probes were transcribed from the linear- 
ized eDNA templates and labeled with digoxigenin- 
l l -UTP under conditions recommended by and 
with reagents from Boehringer Mannheim (India- 
napolis). In situ hybridization was performed as de- 
scribed. 14 Briefly, 5 ixm tissue sections were treated 
with proteinase K (Sigma Chemical Co., St. Louis) 
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Fig. 2. Immunohistochemical analysis i:or PGE 2 in AAA tissue. A, Specific staining within 
macrophage. B, Staining within macrophages and less-intense staining over smooth muscle 
cells. 
and washed in 0.1 mol /L  triethanolamine buffer 
containing digoxigenin-labeled antisense or sense 
RNA probes and incubated at 42 ° C for 18 hours in a 
humidified chamber. After hybridization, the slides 
were washed under stringent conditions, including 
treatment with ribonuclease-A. The sections were 
treated with alkaline phosphatase-conjugated anti- 
digoxigenin antibody and 10% normal sheep serum, 
followed by 5-bromo-4-chloro-3-indoyl phosphate 
and nitroblue tetrazolium as chromogens. After de- 
velopment for 4 to 24 hours in the dark, the color 
reaction was stopped with Milli-Q-water, and the 
slides were stained with nuclear-fast red for final 
histologic analysis. 
RESULTS 
ELISA performed on the conditioned media 
from whole organ aortic wall explant cultures AAA 
showed markedly elevated levels of PGE 2 produc- 
tion as compared with normal aortic specimens 
(67,287 -+ 27,303 pg/ml  vs 1696 _+ 858 pg/ml; 
10 < 0.001). The raw data is depicted in Fig. 1, and 
this clearly demonstrates both the uniformly low 
level of PGE 2 production by normal aorta and the 
markedly elevated levels by aneurysmal orta. Histo- 
logic evaluation demonstrated the inflammatory in- 
filtrate associated with the aortic wall in AAA tissue. 
Immunohistochemical analysis for PGE 2 demon- 
strated staining within the inflammatory infiltrate of 
AAA, with specific staining within macrophage-like 
cells as well as within some smooth muscle cells (Fig. 
2). This staining was similar in all AAA specimens. 
No PGE 2 antigen staining was detected on the nor- 
mal aortic specimens. 
In situ hybridization using a human eDNA cox2 
probe showed hybridization within the macrophage- 
like cells in the inflammatory infiltrate within the 
aortic wall in all of the AAA specimens (Fig. 3). No 
qualitative difference was noted between the AAA 
specimens. In contrast, normal aortic tissue showed 
little or no hybridization with this probe. There was 
little or no expression of coxl in either normal or 
AAA specimens. 
DISCUSSION 
This study documents that AAA tissue in whole 
organ culture produces significant quantities of 
PGE 2 and, conversely, shows that normal aortic tis- 
sue produces very little PGE 2. In addition, PGE 2 was 
localized to the inflammatory infiltrate associated 
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Fig. 3. In situ hybridization for cox2 in AAA tissue. A and B, High-power views of AAA tissue 
demonstrate the specific staining within macrophage-like cells within inflammatory infiltrate. 
with AAA. As would be expected on the basis of the 
organ culture data, no PGE 2 antigen was detected in
normal aortic tissue. In addition, in situ hybridiza- 
tion showed specific staining for the cox2 isozyme of 
cyclooxygenase in macrophage-like c lls within the 
inflammatory infiltrate in AAA specimens. There was 
no appreciable staining for cox2 in normal aortic 
tissue, and coxl was not detected insignificant quan- 
tifies in either AAA or normal aortic tissue. These 
results uggest that PGE 2 is involved in AAA patho- 
genesis and that its expression is dependent on the 
cox2 isozyme in macrophages. 
These results are not surprising because other 
studies have implicated macrophages in the patho- 
genesis of AAA. Macrophages are lmown to play an 
important role in regulating the turnover ofextracel- 
lular matrix (ECM) in both normal and pathologic 
conditions through the secretion of proteases, in- 
cluding MMPs, protease inhibitors, and cytoldnes. 
Levels of MMPs, particularly the 72 kD (MMP-2) 
and 92 kD (MMP-9) gelatinases, which are potent 
elastases, 15are elevated in human AAA tissue and are 
believed to play a role in the pathogenesis oI'AAA. 5,6 
MMP-9 has been localized to macrophages in 
AAAs, 6 as has been urokinase, 13,16 which synergisti- 
cally enhances the ability of macrophages to destroy 
ECM. 17 Levels of plasmin, the end product of urold- 
nase activity and an activator of MMPs, are also 
elevated in AAA tissue. 18 These studies trongly sup- 
port the role of macrophages in the pathogenesis of 
AAA and suggest hat their effects are mediated 
through a synergistic combination of MMPs, uroki- 
nase, and plasmin. 
This study addresses another aspect of the bio- 
logic function ofmacrophages within AAA. In other 
models, MMP expression in macrophages has been 
shown to be dependent on PGE2. 7q° PGE 2 is syn- 
thesized from arachidonic acid, and cyclooxygenase 
(cox) is the rate-limiting enzyme in this pathway. 
There are two isozymes ofwclooxygenase , which are 
encoded by two independently regulated genes, 
cyclooxygenase-1 (cox1) and cyclooxygenase-2 
(cox2). 11,12 The activation of macrophages has been 
previously correlated with the induction of COX2,19 
and our study documents hat cox2 has been induced 
in macrophages within the inflammatory infiltrate of 
AAA. These data, coupled with those of previous 
studies, further implicate macrophages in the patho- 
genesis of AAA. 
Although the primary event hat initiates the for- 
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marion of AAAs is currently not known, therapeuti- 
cally targeting the biologic events--for example, the 
expression of matrix metalloproteinases, which result 
in destruction of the aortic wall--could be a means 
to attenuate aneurysm growth. The data here suggest 
that blocking cox activity could decrease the expres- 
sion of MMPs. This intervention is attractive because 
nonsteroidal antiinflammatory drugs (NSAIDs) that 
inhibit both coxl and cox2 activity are already in 
common use. In fact, we have previously docu- 
mented that indomethacin, aNSAID, attenuates an- 
eurysm growth in an animal model and is associated 
with decreased expression of MMP~9. 2° However, 
NSAID therapy is not benign and is associated with 
untoward side effects, including peptic ulceration, 
increased bleeding, and nephrotoxicity. These side 
effects appear to be mediated by coxl, and cox2 
appears to be associated with response to injury and 
inf lammarion.21, 22 
A recent study performed in rats using NS-398, a 
selective-cox2 inhibitor, demonstrated that proin- 
flammatory prostaglandin synthesis could be effec- 
tively blocked with this drug without the gastric 
ulcerogenic side effects that were seen with indo- 
methacin in the same model. 23 If the pathogenesis of 
AAA is in part dependent on PGE 2 and is mediated 
by cox2 expression in macrophages (as is sug- 
gested by the data presented here), then a selective 
cox2 inhibitor has the potential to prevent or slow 
the growth of AAA. This intervention is particu- 
larly attractive in the setting of small aneurysms. 
Currently, the management of small aneurysms 
(less than 4.0 to 4.5 cm in size) is controversial 
because the risk of rupture is low, but the natural 
history of most is continued expansion, and more 
than 80% of small aneurysms eventually rupture or 
require surgical intervention. If an effective oral 
therapy were available, many patients with small 
aneurysms could avoid surgery, which even in the 
best of circumstances entails morbidity and death 
for some patients. 
CONCLUSION 
We conclude that PGE 2 is associated with AAA 
pathogenesis. Its expression iscontrolled by the cox2 
isoform of cyclooxygenase, which is expressed by 
macrophage-like cells within the inflammatory infil- 
trate associated with the aortic wall in aneurysm 
disease. We further suggest hat cox2 is a potential 
target for pharmacotherapy of AAA. 
We gratefully thank Scott Hausen of Monsanto Corp. 
for providing cDNA probes for coxl  and cox2, Stephen 
Mnich of  Searle, Inc., for providing the monoclonal anti- 
body for PGE2, and Alexander Shaffer of  Searle, Inc., for 
assistance with the PGE 2 ELISA. 
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DISCUSSION 
Dr. William H. Pearce (Chicago, Ill.). I would like to 
compliment Dr. Holmes on his presentation and this 
group in St. Louis who have focused for so many years on 
the pathogenesis ofaneurysms and have contributed signif- 
icantly to our literature. 
Inflammation is a part of atherosclerosis and a part of 
aneurysm disease, and therefore it is not surprising that one 
would find these mediators of inflammation i the aneu- 
rysm specimens. What is interesting and surprising is the 
magnitude of the difference. The levels were almost 1700 
pg/ml in the normal group and more than 67,000 pg/ml 
in the aneurysm group. What I would like to lmow is what 
was the level in the group of normal samples? I think none 
of us will be surprised that a 20-year-old who has not a 
speck of atherosclerosis would probably have different lev- 
els than a 63-year-old who has an aneurysm and atheroscle- 
rosis. In a similar argument, do you have any patients that 
did have atherosclerosis with whom you could make a 
comparison? Every time I perform these studies and com- 
pare the results with those of the atherosclerotic group, I
find that much of the significance will disappear. In sum, I
think this is a very interesting and provocative study that 
gives us an insight into a system that can be manipulated, 
and wouldn't i be interesting inthe future if we could treat 
our patients with aneurysms with nonsteroidal ntiinflam- 
matory drugs? 
I have two questions for you. Could you better charac- 
terize the normal group of your patients? And second, in 
any of your experiments have you performed tissue cul- 
tures where you have given the nonsteroidal ntiinflamma- 
tory drugs and demonstrated a change? 
Dr. Dennis R. Holmes. The group of normal samples 
was obtained from organ transplant donors. All of the 
specimens were examined, and we selected those that dis- 
played no visible evidence of atherosclerosis. Because of 
the limited samples, we did not perform a complete study 
ofatheroocclusive samples. However, we did examine two 
occlusive specimens and found that the level of PGE 2 was 
elevated in those samples. The level was riot as high as that 
in the aneurysm group, but it was significantly higher than 
in normal tissues. 
In addition, we did culture aneurysm tissue in the 
presence of indomethacin, and we found that the PGE 2 
production was reduced to almost undetectable levels. 
